查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
醫療 3D 生物列印市場：按產品/解決方案、按技術、按應用、按最終用戶：2023-2032 年全球機會分析和產業預測
市場調查報告書
商品編碼
1415009

醫療 3D 生物列印市場：按產品/解決方案、按技術、按應用、按最終用戶：2023-2032 年全球機會分析和產業預測

3D Bioprinting in Medical Market By Products and solutions, By Technology, By Application, By End users : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 316 Pages | 商品交期: 2-3個工作天內

價格

2022年，醫療3D生物列印市場價值為11億美元，預計2023年至2032年複合年成長率為15.5%，到2032年將達到49億美元。

3D生物列印在醫療市場-IMG1

然而，生物列印機的高成本、缺乏與3D生物列印機核准相關的結構化法規結構、對版權和專利侵權的擔憂、3D生物列印醫療設備的生物相容性問題以及技術專業知識的稀缺是阻礙的主要因素市場成長。相反，新興國家開拓的市場預計將為市場公司提供利潤豐厚的機會。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 慢性病盛行率上升
      • 3D生物列印在生物醫學應用的使用迅速增加
      • 3D生物列印的進展
    • 抑制因素
      • 3D 列印相關的高成本
      • 缺乏熟練的專業人員
    • 機會
      • 新興市場的成長機會
      • 製藥應用的增加

第 4 章 醫療 3D 生物列印市場：依產品和解決方案分類

  • 概述
  • 生物印表機
  • 耗材及配件
  • 軟體和服務

第5章醫療 3D 生物列印市場：依技術分類

  • 概述
  • 擠壓生物列印
  • 噴墨生物列印
  • 雷射輔助生物列印
  • 其他

第6章 醫療 3D 生物列印市場：依應用分類

  • 概述
  • 組織工程與再生醫學
  • 藥物研發發現和藥物開發
  • 其他

第 7 章 醫療 3D 生物列印市場：依最終用戶分類

  • 概述
  • 生物技術和製藥公司
  • 學術/研究機構
  • 其他

第 8 章 醫療 3D 生物列印市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 南非
    • 沙烏地阿拉伯
    • 其他

第9章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2022年）

第10章 公司簡介

  • Advanced Solutions, Inc.
  • CollPlant Biotechnologies Ltd
  • Shining 3D
  • Organovo Holdings, Inc.
  • Medprin
  • Cyfuse Biomedical KK
  • Desktop Metal, Inc.
  • REGEMAT 3D
  • 3D Systems Corporation
  • BICO
Product Code: A171553

According to a new report published by Allied Market Research, titled, "3D Bioprinting in Medical Market," The 3d bioprinting in medical market was valued at $1.1 billion in 2022, and is estimated to reach $4.9 billion by 2032, growing at a CAGR of 15.5% from 2023 to 2032.

3D Bioprinting in Medical Market - IMG1

However, high costs of bioprinters, lack of structured regulatory frameworks related to approvals for 3D bioprinters, copyright & patent infringement concerns, biocompatibility issues of 3D-bioprinted medical devices, and lack of technical expertise are the major factors hampering the growth of the market. Conversely, untapped markets in the developing countries are expected to provide lucrative opportunities for the market players.

The 3D bioprinting in medical market is segmented into products & solutions, technology, application, end user, and region. By products & solutions, the market is classified into bioprinters, consumables & accessories, and software & services. By technology, the market is classified into extrusion-based bioprinting, inkjet based bioprinting, laser assisted bioprinting, and others. By application, the market is segregated into tissue engineering & regenerative medicine, drug discovery & development, and others. By end user, the market is classified into biotechnology & pharmaceutical companies, academic & research institutes, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global 3D bioprinting in medical market are Organovo Holdings, Inc., Cyfuse Biomedical K.K., BICO, REGEMAT 3D, Desktop Metal, Inc., Medprin, Shining 3D, CollPlant Biotechnologies Ltd, Advanced Solutions, Inc., and 3D Systems Corporation. Key players operating in the market have adopted product launch, partnership, agreement, acquisition, collaboration, expansion, and product upgrade as their key strategies to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the 3d bioprinting in medical market analysis from 2022 to 2032 to identify the prevailing 3d bioprinting in medical market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the 3d bioprinting in medical market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global 3d bioprinting in medical market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By End users

  • Biotechnology and pharmaceutical companies
  • Academic and research institutes
  • Others

By Products and solutions

  • Bioprinters
  • Consumables and accessories
  • Software and services

By Technology

  • Extrusion based bioprinting
  • Inkjet based bioprinting
  • Laser assisted bioprinting
  • Others

By Application

  • Tissue engineering and regenerative medicine
  • Drug discovery and development
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Cyfuse Biomedical K.K.
    • BICO
    • Desktop Metal, Inc.
    • Medprin
    • CollPlant Biotechnologies Ltd
    • 3D Systems Corporation
    • Organovo Holdings, Inc.
    • REGEMAT 3D
    • Shining 3D
    • Advanced Solutions, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. High intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of chronic diseases
      • 3.4.1.2. Surge in usage of 3D bioprinting in biomedical applications
      • 3.4.1.3. Advancements in 3D bioprinting
    • 3.4.2. Restraints
      • 3.4.2.1. High cost associated with 3D printing
      • 3.4.2.2. Dearth of skilled professionals
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets
      • 3.4.3.2. Rise in pharmaceutical applications

CHAPTER 4: 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Bioprinters
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Consumables and accessories
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Software and services
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Extrusion based bioprinting
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Inkjet based bioprinting
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Laser assisted bioprinting
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Tissue engineering and regenerative medicine
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Drug discovery and development
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Biotechnology and pharmaceutical companies
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Academic and research institutes
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: 3D BIOPRINTING IN MEDICAL MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Products and solutions
    • 8.2.3. Market size and forecast, by Technology
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End users
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Products and solutions
      • 8.2.6.1.2. Market size and forecast, by Technology
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by End users
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Products and solutions
      • 8.2.6.2.2. Market size and forecast, by Technology
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by End users
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Products and solutions
      • 8.2.6.3.2. Market size and forecast, by Technology
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by End users
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Products and solutions
    • 8.3.3. Market size and forecast, by Technology
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End users
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Products and solutions
      • 8.3.6.1.2. Market size and forecast, by Technology
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by End users
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Products and solutions
      • 8.3.6.2.2. Market size and forecast, by Technology
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by End users
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Products and solutions
      • 8.3.6.3.2. Market size and forecast, by Technology
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by End users
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Products and solutions
      • 8.3.6.4.2. Market size and forecast, by Technology
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by End users
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Products and solutions
      • 8.3.6.5.2. Market size and forecast, by Technology
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by End users
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Products and solutions
      • 8.3.6.6.2. Market size and forecast, by Technology
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by End users
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Products and solutions
    • 8.4.3. Market size and forecast, by Technology
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End users
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Products and solutions
      • 8.4.6.1.2. Market size and forecast, by Technology
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by End users
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Products and solutions
      • 8.4.6.2.2. Market size and forecast, by Technology
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by End users
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Products and solutions
      • 8.4.6.3.2. Market size and forecast, by Technology
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by End users
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Market size and forecast, by Products and solutions
      • 8.4.6.4.2. Market size and forecast, by Technology
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by End users
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Products and solutions
      • 8.4.6.5.2. Market size and forecast, by Technology
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by End users
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Products and solutions
      • 8.4.6.6.2. Market size and forecast, by Technology
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by End users
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Products and solutions
    • 8.5.3. Market size and forecast, by Technology
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End users
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Products and solutions
      • 8.5.6.1.2. Market size and forecast, by Technology
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by End users
      • 8.5.6.2. South Africa,
      • 8.5.6.2.1. Market size and forecast, by Products and solutions
      • 8.5.6.2.2. Market size and forecast, by Technology
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by End users
      • 8.5.6.3. Saudi Arabia
      • 8.5.6.3.1. Market size and forecast, by Products and solutions
      • 8.5.6.3.2. Market size and forecast, by Technology
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by End users
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Products and solutions
      • 8.5.6.4.2. Market size and forecast, by Technology
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by End users

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Advanced Solutions, Inc.
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Key strategic moves and developments
  • 10.2. CollPlant Biotechnologies Ltd
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Shining 3D
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
  • 10.4. Organovo Holdings, Inc.
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Business performance
    • 10.4.7. Key strategic moves and developments
  • 10.5. Medprin
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Cyfuse Biomedical K.K.
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
  • 10.7. Desktop Metal, Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
    • 10.7.7. Key strategic moves and developments
  • 10.8. REGEMAT 3D
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. 3D Systems Corporation
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
    • 10.9.7. Key strategic moves and developments
  • 10.10. BICO
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance
    • 10.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 02. 3D BIOPRINTING IN MEDICAL MARKET FOR BIOPRINTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. 3D BIOPRINTING IN MEDICAL MARKET FOR CONSUMABLES AND ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. 3D BIOPRINTING IN MEDICAL MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 06. 3D BIOPRINTING IN MEDICAL MARKET FOR EXTRUSION BASED BIOPRINTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. 3D BIOPRINTING IN MEDICAL MARKET FOR INKJET BASED BIOPRINTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. 3D BIOPRINTING IN MEDICAL MARKET FOR LASER ASSISTED BIOPRINTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 11. 3D BIOPRINTING IN MEDICAL MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. 3D BIOPRINTING IN MEDICAL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 15. 3D BIOPRINTING IN MEDICAL MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. 3D BIOPRINTING IN MEDICAL MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. 3D BIOPRINTING IN MEDICAL MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 24. U.S. 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 25. U.S. 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 26. U.S. 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. U.S. 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 28. CANADA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 29. CANADA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 30. CANADA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. CANADA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 42. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 49. UK 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 50. UK 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 51. UK 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. UK 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 53. ITALY 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 54. ITALY 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 55. ITALY 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. ITALY 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 61. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 62. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 65. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 66. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 71. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 72. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 74. CHINA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 75. CHINA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 76. CHINA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. CHINA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 78. INDIA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 79. INDIA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 80. INDIA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. INDIA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 82. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 83. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 84. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 96. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 98. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 99. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 100. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 101. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 102. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 103. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 104. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 105. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 106. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 107. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 108. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 109. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 110. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 114. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 115. ADVANCED SOLUTIONS, INC.: KEY EXECUTIVES
  • TABLE 116. ADVANCED SOLUTIONS, INC.: COMPANY SNAPSHOT
  • TABLE 117. ADVANCED SOLUTIONS, INC.: PRODUCT SEGMENTS
  • TABLE 118. ADVANCED SOLUTIONS, INC.: PRODUCT PORTFOLIO
  • TABLE 119. ADVANCED SOLUTIONS, INC.: KEY STRATERGIES
  • TABLE 120. COLLPLANT BIOTECHNOLOGIES LTD: KEY EXECUTIVES
  • TABLE 121. COLLPLANT BIOTECHNOLOGIES LTD: COMPANY SNAPSHOT
  • TABLE 122. COLLPLANT BIOTECHNOLOGIES LTD: PRODUCT SEGMENTS
  • TABLE 123. COLLPLANT BIOTECHNOLOGIES LTD: PRODUCT PORTFOLIO
  • TABLE 124. COLLPLANT BIOTECHNOLOGIES LTD: KEY STRATERGIES
  • TABLE 125. SHINING 3D: KEY EXECUTIVES
  • TABLE 126. SHINING 3D: COMPANY SNAPSHOT
  • TABLE 127. SHINING 3D: PRODUCT SEGMENTS
  • TABLE 128. SHINING 3D: PRODUCT PORTFOLIO
  • TABLE 129. ORGANOVO HOLDINGS, INC.: KEY EXECUTIVES
  • TABLE 130. ORGANOVO HOLDINGS, INC.: COMPANY SNAPSHOT
  • TABLE 131. ORGANOVO HOLDINGS, INC.: PRODUCT SEGMENTS
  • TABLE 132. ORGANOVO HOLDINGS, INC.: PRODUCT PORTFOLIO
  • TABLE 133. ORGANOVO HOLDINGS, INC.: KEY STRATERGIES
  • TABLE 134. MEDPRIN: KEY EXECUTIVES
  • TABLE 135. MEDPRIN: COMPANY SNAPSHOT
  • TABLE 136. MEDPRIN: PRODUCT SEGMENTS
  • TABLE 137. MEDPRIN: PRODUCT PORTFOLIO
  • TABLE 138. CYFUSE BIOMEDICAL K.K.: KEY EXECUTIVES
  • TABLE 139. CYFUSE BIOMEDICAL K.K.: COMPANY SNAPSHOT
  • TABLE 140. CYFUSE BIOMEDICAL K.K.: PRODUCT SEGMENTS
  • TABLE 141. CYFUSE BIOMEDICAL K.K.: PRODUCT PORTFOLIO
  • TABLE 142. DESKTOP METAL, INC.: KEY EXECUTIVES
  • TABLE 143. DESKTOP METAL, INC.: COMPANY SNAPSHOT
  • TABLE 144. DESKTOP METAL, INC.: PRODUCT SEGMENTS
  • TABLE 145. DESKTOP METAL, INC.: PRODUCT PORTFOLIO
  • TABLE 146. DESKTOP METAL, INC.: KEY STRATERGIES
  • TABLE 147. REGEMAT 3D: KEY EXECUTIVES
  • TABLE 148. REGEMAT 3D: COMPANY SNAPSHOT
  • TABLE 149. REGEMAT 3D: PRODUCT SEGMENTS
  • TABLE 150. REGEMAT 3D: PRODUCT PORTFOLIO
  • TABLE 151. 3D SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 152. 3D SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 153. 3D SYSTEMS CORPORATION: PRODUCT SEGMENTS
  • TABLE 154. 3D SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 155. 3D SYSTEMS CORPORATION: KEY STRATERGIES
  • TABLE 156. BICO: KEY EXECUTIVES
  • TABLE 157. BICO: COMPANY SNAPSHOT
  • TABLE 158. BICO: PRODUCT SEGMENTS
  • TABLE 159. BICO: PRODUCT PORTFOLIO
  • TABLE 160. BICO: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF 3D BIOPRINTING IN MEDICAL MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN 3D BIOPRINTING IN MEDICAL MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN 3D BIOPRINTING IN MEDICAL MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. HIGH INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR BIOPRINTERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR CONSUMABLES AND ACCESSORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR EXTRUSION BASED BIOPRINTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR INKJET BASED BIOPRINTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR LASER ASSISTED BIOPRINTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 28. 3D BIOPRINTING IN MEDICAL MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 29. U.S. 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. CANADA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. UK 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. ITALY 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. CHINA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. INDIA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 52. COMPETITIVE DASHBOARD
  • FIGURE 53. COMPETITIVE HEATMAP: 3D BIOPRINTING IN MEDICAL MARKET
  • FIGURE 54. TOP PLAYER POSITIONING, 2022
  • FIGURE 55. COLLPLANT BIOTECHNOLOGIES LTD: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 56. COLLPLANT BIOTECHNOLOGIES LTD: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 57. ORGANOVO HOLDINGS, INC.: NET REVENUE, 2022-2023 ($MILLION)
  • FIGURE 58. DESKTOP METAL, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 59. DESKTOP METAL, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. 3D SYSTEMS CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 61. 3D SYSTEMS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. 3D SYSTEMS CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. BICO: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. BICO: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. BICO: REVENUE SHARE BY REGION, 2022 (%)